Lilly Target definition

Lilly Target has the meaning set forth in Section 4.2.1.
Sample 1Sample 2
Lilly Target means [***].
Sample 1Sample 2
Lilly Target means (i) gamma secretase/NOTCH, (ii) PD-L1/PD-1, (iii) TGF-b, (iv) PI3K-AKT-MTOR and (v)
Sample 1

Examples of Lilly Target in a sentence

  • For avoidance of doubt, the exclusivity obligations set forth in Section 7.1 shall continue to apply for the duration of such obligations set forth therein with respect to compounds and products Directed To a Target that remains a Lilly Target.

  • Solely for purposes of this Section 7.1.1, and without otherwise modifying the definition of “Lilly Target” for any other purpose, “Lilly Target” shall include the Target of which such Lilly Target is a specific adenosine, the gene coding for such Target, and any protein product translated from such Target.

  • If ProQR or any of its Affiliates determines that it has unintentionally Developed a compound Directed to a Lilly Target as described above, during the relevant period of restriction indicated above, ProQR and its Affiliate shall cease any and all Development activities with respect to such Compound and shall not permit or enable any Third Party to conduct further Development activities with respect to such Compound.

  • For clarity, except for rights necessary for Zymeworks to carry out its responsibilities under the Research Program as contemplated hereunder or as otherwise specifically granted herein, Lilly is not granting Zymeworks any rights, implicitly, explicitly or otherwise to use the Lilly Target Pair or Lilly Sequences for any purpose.

  • For clarity, each of the Development Milestone Payments will be payable only once per Lilly Target for the first Product to achieve such milestone with respect to such Lilly Target regardless of how many Products may be directed to the same Lilly Target or how many times a given Development Milestone Event is achieved with respect to a given Lilly Target.

  • Such Proposed Replacement Target shall become a Lilly Replacement Target and, therefore, subject to the procedure set forth in Section 3.1.3(a), also become a Lilly Target and the replaced Target shall be deemed a discontinued target (“Lilly Discontinued Target”).

  • With respect to each Lilly Target Pair, Zymeworks hereby grants to Lilly an exclusive license under the Zymeworks Intellectual Property (including Zymeworks’ interest in Joint Inventions) to (a) make, use and import Antibodies Directed To such Lilly Target Pair for incorporation into Products and (b) make, use, offer to sell, sell, and import Products that incorporate such Antibodies in the Field in the Territory as of the Effective Date and during the Term of the Agreement (the “License”).

  • Notwithstanding the foregoing, Lilly’s reporting obligations under this Section 4.5.1 are limited to the Product or Compound component of a Lilly Product and Lilly is not obligated under this Section 4.5.1 to provide Licensee with any notice or information that is related solely to a Lilly Target Molecule.

  • The SSA-VV and SSA-I for the constant-temperature DPD method were tested using the standard DPD fluid (13), where details of the conservative forces for this model are given in appendix B.

  • In view of the current international scenario of the Covid-19 pandemic which still requires measures to curb the spread of the virus, the Company's absolute priority continues to be the health of its employees and customers.


More Definitions of Lilly Target

Lilly Target means each (a) Pre-Signing Lilly Target, (b) Additional Target, and
Sample 1

Related to Lilly Target

  • Soft Target means a target that will suffer minimum damage and cause minimum damage to the subject vehicle in the event of a collision.

  • KPI Target means the acceptable performance level for a KPI as set out in each KPI;

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • ISIS means the department’s individualized services information system.

  • GSK will have the meaning set forth in the Preamble.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Development Candidate means a Collaboration Compound designated by Biogen Idec as a Development Candidate in accordance with Section 2.6.

  • Development Milestone Event has the meaning set forth in Section 7.1.

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Development Milestone Payment shall have the meaning set forth in Section 9.2(a).

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Lilly has the meaning set forth in the Preamble.

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Acquisition Target means any Person becoming a Subsidiary of the Company after the date hereof; any Person that is merged into or consolidated with the Company or any Subsidiary of the Company after the date hereof; or any Person with respect to which all or a substantial part of that Person’s assets are acquired by the Company or any Subsidiary of the Company after the date hereof.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Program Patent Rights means any Patent Rights that contain one or more claims that cover Program Inventions.

  • Research Program Term has the meaning set forth in Section 2.2.

  • Merck has the meaning set forth in the preamble.

  • Novartis shall have the meaning set forth in the Preamble.

  • Valid write-in candidate means a candidate who has qualified as a write-in

  • Licensed Compound means [***].

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • EBITDA Target means the Company's projected earnings before interest, taxes, one-time transition expenses, non-cash compensation expense charges, depreciation and amortization, as contained in the Company's budget for the Applicable Period and which is approved by the Board (without reference to any adjustments or revision, upwards or downwards, to such projected earnings which are subsequently approved by the Board as part of any subsequent revision to such budget), and (ii) the term "Financial Results" shall mean the Company's EBITDA calculated by reference to the Company's financial statements for the Applicable Period as filed with the Securities and Exchange Commission (the "SEC").

  • Milestone Event has the meaning set forth in Section 8.4.

  • Licensed Compounds means any EZH2 Compound(s) that is: